Strategies to improve access to cognitive behavioral therapies for anxiety disorders: A scoping review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 18 12 2020
accepted: 09 02 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 22 4 2022
Statut: epublish

Résumé

Strategies to improve access to evidence-based psychological treatments (EBPTs) include but are not limited to implementation strategies. No currently available framework accounts for the full scope of strategies available to allow stakeholders to improve access to EBPTs. Anxiety disorders are common and impactful mental conditions for which EBPTs, especially cognitive-behavioral therapies (CBT), are well-established yet often hard to access. Describe and classify the various strategies reported to improve access to CBT for anxiety disorders. Scoping review with a keyword search of several databases + additional grey literature documents reporting on strategies to improve access to CBT for anxiety disorders. A thematic and inductive analysis of data based on grounded theory principles was conducted using NVivo. We propose to classify strategies to improve access to CBT for anxiety disorders as either "Contributing to the evidence base," "Identifying CBT delivery modalities to adopt in practice," "Building capacity for CBT delivery," "Attuning the process of access to local needs," "Engaging potential service users," or "Improving programs and policies." Each of these strategies is defined, and critical information for their operationalization is provided, including the actors that could be involved in their implementation. This scoping review highlights gaps in implementation research regarding improving access to EBPTs that should be accounted for in future studies.

Sections du résumé

BACKGROUND
Strategies to improve access to evidence-based psychological treatments (EBPTs) include but are not limited to implementation strategies. No currently available framework accounts for the full scope of strategies available to allow stakeholders to improve access to EBPTs. Anxiety disorders are common and impactful mental conditions for which EBPTs, especially cognitive-behavioral therapies (CBT), are well-established yet often hard to access.
OBJECTIVE
Describe and classify the various strategies reported to improve access to CBT for anxiety disorders.
METHODS
Scoping review with a keyword search of several databases + additional grey literature documents reporting on strategies to improve access to CBT for anxiety disorders. A thematic and inductive analysis of data based on grounded theory principles was conducted using NVivo.
RESULTS
We propose to classify strategies to improve access to CBT for anxiety disorders as either "Contributing to the evidence base," "Identifying CBT delivery modalities to adopt in practice," "Building capacity for CBT delivery," "Attuning the process of access to local needs," "Engaging potential service users," or "Improving programs and policies." Each of these strategies is defined, and critical information for their operationalization is provided, including the actors that could be involved in their implementation.
IMPLICATIONS
This scoping review highlights gaps in implementation research regarding improving access to EBPTs that should be accounted for in future studies.

Identifiants

pubmed: 35231039
doi: 10.1371/journal.pone.0264368
pii: PONE-D-20-39826
pmc: PMC8887746
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0264368

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Psychol Rev. 2010 Mar;30(2):194-202
pubmed: 19942331
Behav Res Ther. 2014 Mar;54:49-53
pubmed: 24530499
PLoS One. 2015 May 04;10(5):e0123997
pubmed: 25938241
J Int Med Res. 2020 Jun;48(6):300060520928686
pubmed: 32527170
Transl Behav Med. 2015 Sep;5(3):247-53
pubmed: 26327929
J Med Internet Res. 2020 Jul 7;22(7):e18220
pubmed: 32673226
Psychiatry Investig. 2019 Jan;16(1):37-49
pubmed: 30122031
J Anxiety Disord. 2021 Apr;79:102385
pubmed: 33774557
Aust N Z J Psychiatry. 2017 Dec;51(12):1227-1239
pubmed: 27733709
J Anxiety Disord. 2013 Dec;27(8):793-801
pubmed: 23602058
Harv Rev Psychiatry. 2010 Mar-Apr;18(2):80-95
pubmed: 20235773
Internet Interv. 2019 Aug 15;18:100263
pubmed: 31890616
Behav Ther. 2014 Nov;45(6):731-44
pubmed: 25311284
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Internet Interv. 2018 May 31;13:24-29
pubmed: 30206515
Behav Ther. 2013 Dec;44(4):603-8
pubmed: 24094785
Cyberpsychol Behav Soc Netw. 2010 Aug;13(4):407-21
pubmed: 20712499
J Med Internet Res. 2017 Nov 24;19(11):e398
pubmed: 29175809
Psychother Res. 2020 Jul;30(6):776-787
pubmed: 31510890
Implement Sci. 2017 Nov 3;12(1):125
pubmed: 29100551
J Med Internet Res. 2020 Aug 12;22(8):e18033
pubmed: 32784186
Behav Ther. 2012 Sep;43(3):468-81
pubmed: 22697437
Behav Cogn Psychother. 2013 May;41(3):359-64
pubmed: 23017813
JMIR Form Res. 2019 May 15;3(2):e13446
pubmed: 31094320
Cogn Behav Ther. 2017 Sep;46(5):404-420
pubmed: 28270059
Psychiatry Res. 2020 Jan;283:112376
pubmed: 31036287
Implement Sci. 2015 Aug 07;10:109
pubmed: 26249843
Behav Res Ther. 2015 May;68:1-12
pubmed: 25768982
J Affect Disord. 2017 Mar 01;210:1-13
pubmed: 27988373
BMJ Open Qual. 2018 Jan 9;7(1):e000066
pubmed: 29333493
Behav Modif. 2021 Aug 28;:1454455211040051
pubmed: 34459271
Depress Anxiety. 2013 Oct;30(10):917-29
pubmed: 23408488
J Anxiety Disord. 2021 Mar;78:102345
pubmed: 33395601
Front Psychiatry. 2019 Oct 25;10:773
pubmed: 31708821
Cogn Behav Ther. 2021 Jan;50(1):67-87
pubmed: 32870126
J Med Internet Res. 2016 Jan 13;18(1):e10
pubmed: 26764181
Indian J Psychol Med. 2015 Jan-Mar;37(1):20-5
pubmed: 25722507
Front Psychol. 2019 Sep 10;10:1758
pubmed: 31551840
J Clin Psychiatry. 2013 Jun;74(6):595-602
pubmed: 23842011
Depress Anxiety. 2003;17(3):173-9
pubmed: 12768651
Cognit Ther Res. 2017 Apr;41(2):252-265
pubmed: 28435174
Implement Sci. 2013 Dec 01;8:139
pubmed: 24289295
Aust Health Rev. 2017 Mar;41(1):82-88
pubmed: 27007500
JAMA Psychiatry. 2017 Sep 1;74(9):875-884
pubmed: 28768327
Behav Res Ther. 2019 Sep;120:103446
pubmed: 31376708
Int Rev Psychiatry. 2011 Aug;23(4):318-27
pubmed: 22026487
Telemed J E Health. 2016 May;22(5):450-7
pubmed: 26461235
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Implement Sci. 2012 Mar 09;7:1-11
pubmed: 22404963
FASEB J. 2008 Feb;22(2):338-42
pubmed: 17884971
Psychol Med. 2013 May;43(5):897-910
pubmed: 22781489
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
PLoS One. 2020 Aug 13;15(8):e0237061
pubmed: 32790718
Behav Cogn Psychother. 2013 Jul;41(4):383-97
pubmed: 23676553
Sci Rep. 2020 Mar 9;10(1):4288
pubmed: 32152429
Internet Interv. 2018 Jul 26;13:108-115
pubmed: 30206525
Brain Behav. 2016 Jun 05;6(7):e00497
pubmed: 27458547
Cogn Behav Ther. 2018 Jan;47(1):62-75
pubmed: 28714775
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
JMIR Ment Health. 2020 Apr 23;7(4):e17157
pubmed: 32324150
World Psychiatry. 2016 Oct;15(3):245-258
pubmed: 27717254
J Anxiety Disord. 2013 Dec;27(8):802-4
pubmed: 24148748
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Behav Ther. 2016 Mar;47(2):166-83
pubmed: 26956650
Am J Community Psychol. 2008 Jun;41(3-4):171-81
pubmed: 18302018
JAMA Psychiatry. 2016 Feb;73(2):150-8
pubmed: 26719969
PLoS One. 2019 Apr 9;14(4):e0214715
pubmed: 30964883
Scand J Psychol. 2020 Dec;61(6):846-854
pubmed: 32705703
J Anxiety Disord. 2009 Dec;23(8):1086-90
pubmed: 19640675
BMC Psychiatry. 2018 Aug 16;18(1):260
pubmed: 30115041
Trials. 2019 May 24;20(1):284
pubmed: 31126337
Psychol Med. 2020 Dec 02;:1-11
pubmed: 33261700
J Child Psychol Psychiatry. 2019 Apr;60(4):455-472
pubmed: 29900543
J Consult Clin Psychol. 2018 Jun;86(6):493-504
pubmed: 29781648
Psychiatr Ann. 2021 Aug;51(5):226-230
pubmed: 34433988
BMC Health Serv Res. 2020 Mar 12;20(1):190
pubmed: 32164706
BMC Health Serv Res. 2012 Aug 13;12:249
pubmed: 22889290
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
Adm Policy Ment Health. 2013 Mar;40(2):87-95
pubmed: 22001968
Depress Anxiety. 2012 Jun;29(6):465-70
pubmed: 22730311
BJPsych Open. 2018 Oct 02;4(5):411-418
pubmed: 30294451
Harv Rev Psychiatry. 2017 May/Jun;25(3):103-113
pubmed: 28475502
J Consult Clin Psychol. 2017 Oct;85(10):988-999
pubmed: 28650193
Depress Anxiety. 2020 Oct;37(10):1007-1016
pubmed: 32390315
Curr Psychiatry Rep. 2020 May 13;22(7):32
pubmed: 32405657
Evid Based Ment Health. 2016 Aug;19(3):e10-2
pubmed: 27356982
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
JMIR Serious Games. 2018 Nov 07;6(4):e10965
pubmed: 30404770
J Psychosom Res. 2019 Oct;125:109812
pubmed: 31442844
Depress Anxiety. 2012 Oct;29(10):874-82
pubmed: 22767410
J Med Internet Res. 2021 Mar 24;23(3):e24387
pubmed: 33759801
J Med Internet Res. 2013 Nov 19;15(11):e258
pubmed: 24252663
Am J Geriatr Psychiatry. 2015 Nov;23(11):1172-8
pubmed: 26245880
Br J Clin Psychol. 2010 Nov;49(Pt 4):491-505
pubmed: 19878622
Focus (Am Psychiatr Publ). 2018 Oct;16(4):363-369
pubmed: 31975928
BMC Psychiatry. 2014;14 Suppl 1:S1
pubmed: 25081580
J Anxiety Disord. 2014 Dec;28(8):884-93
pubmed: 25445078
Prim Care Companion J Clin Psychiatry. 2010;12(4):
pubmed: 21085550
Stud Health Technol Inform. 2015;219:197-201
pubmed: 26799907
Aust J Prim Health. 2014;20(1):62-73
pubmed: 23217591

Auteurs

Jean-Daniel Carrier (JD)

Department of family medicine and emergency medicine, PRIMUS research group, Université de Sherbrooke, Sherbrooke, Canada.
Department of psychiatry, Université de Sherbrooke, Sherbrooke, Canada.

Frances Gallagher (F)

School of nursing, Université de Sherbrooke, Sherbrooke, Canada.
Centre de recherche du CHUS, Sherbrooke, Canada.

Alain Vanasse (A)

Department of family medicine and emergency medicine, PRIMUS research group, Université de Sherbrooke, Sherbrooke, Canada.
Centre de recherche du CHUS, Sherbrooke, Canada.

Pasquale Roberge (P)

Department of family medicine and emergency medicine, PRIMUS research group, Université de Sherbrooke, Sherbrooke, Canada.
Department of psychiatry, Université de Sherbrooke, Sherbrooke, Canada.
Centre de recherche du CHUS, Sherbrooke, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH